IDH2 and central nervous system cancer: Interference with the normal activity of dioxygenases disrupts histone and DNA methylation patterns, leading to the signature global DNA hypermethylation phenotype seen in IDH-mutant gliomas, known as the Glioma CpG Island Methylator Phenotype (G-CIMP) (2).